Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001104659-26-016685·Cherington Charles
Schedule 13D ownership disclosure
ERNEXA THERAPEUTICS INC
Common Stock, par value $0.005 per share · CUSIP: 114082308
Event date: 2026-02-10
- Filing-level shares
- 10,791,335.00
- Percent of class
- 34.7%
- Charles CheringtonReported CIK 0001448698
Shares: 10,791,335.00 · Class: 34.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-26-016685
- Form type
- SCHEDULE 13D/A
- Filer
- Cherington Charles
- CIK
- CIK 1448698
- Filed
- Feb 17, 2026
- Reporting period
- Feb 10, 2026
- Description
- Schedule 13D beneficial ownership